HPM — Hipromine SA Share Price
Last trade - 00:00- PLN211.17m
- PLN296.81m
- PLN2.03m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.02 | ||
| Price to Tang. Book | 3.08 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 103.91 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.84% | ||
| Return on Equity | -35.86% | ||
| Operating Margin | -964.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | n/a | 1.17 | 1.67 | 1.83 | 2.03 | n/a | n/a | 20.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hipromine SA is a Poland-based company operating as a alternative source of protein based products supplier. The Company is engaged in production of protein products for pet food and fodder for fish farming based on industrial insects breeding. It provides its products from production process to the final product.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 11th, 2015
- Public Since
- July 14th, 2022
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 887,261
- Address
- ul. Poznanska 12F, Robakowo, 62-023
- Web
- https://hipromine.com/
- Phone
- Auditors
- 4AUDYT Sp. z o.o.
Upcoming Events for HPM
Similar to HPM
7Fit SA
Warsaw Stock Exchange
Agroliga
Warsaw Stock Exchange
Agroton Public
Warsaw Stock Exchange
Astarta Holding
Warsaw Stock Exchange
Biomass Energy Project SA
Warsaw Stock Exchange
FAQ
As of Today at 19:10 UTC, shares in Hipromine SA are trading at PLN238.00. This share price information is delayed by 15 minutes.
Shares in Hipromine SA last closed at PLN238.00 and the price had moved by +3.03% over the past 365 days. In terms of relative price strength the Hipromine SA share price has underperformed the FTSE Global All Cap Index by -3.27% over the past year.
There is no consensus recommendation for this security.
Hipromine SA does not currently pay a dividend.
Hipromine SA does not currently pay a dividend.
Hipromine SA does not currently pay a dividend.
To buy shares in Hipromine SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN238.00, shares in Hipromine SA had a market capitalisation of PLN211.17m.
Here are the trading details for Hipromine SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: HPM
Based on an overall assessment of its quality, value and momentum Hipromine SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hipromine SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +1.48%.
As of the last closing price of PLN238.00, shares in Hipromine SA were trading +3.1% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hipromine SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN238.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hipromine SA's directors